Jeng-Sheng Chang

Title: Jeng-Sheng Chang: Innovator in Kawasaki Disease Diagnosis and Treatment

Introduction

Jeng-Sheng Chang is a notable inventor based in Taichung, Taiwan. He has made significant contributions to the field of medical diagnostics, particularly in relation to Kawasaki disease. His innovative approach has the potential to improve the diagnosis and treatment of this condition.

Latest Patents

Jeng-Sheng Chang holds a patent for a method of diagnosing, treating, or monitoring Kawasaki disease in a subject. This patent describes a method that includes detecting the level of specific biomarkers in a sample obtained from the subject. The biomarkers identified in his patent include IL-7F, sCD40L, MPIF-1, E-selectin, IP-10, and IL-33. The levels of these biomarkers are compared to a cut-off level to determine the appropriate diagnosis or treatment. Additionally, the patent outlines a kit designed for carrying out this method.

Career Highlights

Chang is affiliated with Academia Sinica, a prestigious research institution in Taiwan. His work at this institution has allowed him to focus on innovative research that addresses critical health issues. His dedication to advancing medical science is evident through his patent and ongoing research efforts.

Collaborations

Jeng-Sheng Chang has collaborated with esteemed colleagues such as Yuan-Tsong Chen and Jer-Yuarn Wu. These collaborations have likely contributed to the depth and impact of his research in the field of Kawasaki disease.

Conclusion

Jeng-Sheng Chang's contributions to the diagnosis and treatment of Kawasaki disease highlight his role as an innovator in medical science. His patent reflects a significant advancement in understanding and addressing this condition. Through his work at Academia Sinica and collaborations with other researchers, Chang continues to make strides in improving healthcare outcomes.